|
Market Closed -
Sao Paulo
16:02:10 05/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 143.40 BRL | +3.91% |
|
0.00% | +19.38% |
| 10-09 | Exelixis' Zanzalintinib Clinical Trials for Cancer Highly Likely to Succeed, RBC Says | MT |
| 10-09 | RBC Raises Price Target on Exelixis to $51 From $45, Keeps Sector Perform Rating | MT |
| Market Cap | 15.95B 80.04B 14.2B 13.16B 11.93B 22.41B 1,511B 22.79B 158B 62.04B 791B 59.85B 58.6B 2,523B | P/E 2026 * |
19.9x | P/E 2027 * | 16.4x |
|---|---|---|---|---|---|
| Enterprise Value | 15.21B 76.31B 13.54B 12.55B 11.37B 21.37B 1,441B 21.73B 151B 59.15B 754B 57.05B 55.87B 2,406B | EV / Sales 2026 * |
5.95x | EV / Sales 2027 * | 4.94x |
| Free-Float |
98.15% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Exelixis, Inc.
| 1 day | +3.91% | ||
| Current month | +4.37% | ||
| 1 month | +4.37% | ||
| 3 months | +6.68% | ||
| 6 months | +29.33% | ||
| Current year | +19.38% |
| 1 month | 143.4 |  | 143.4 |
| Current year | 104.72 | | 143.4 |
| 1 year | 98.24 | | 143.4 |
| 3 years | 50.71 | | 143.4 |
| 5 years | 40 | | 143.4 |
| 10 years | 40 | | 143.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 22/07/2010 | |
| Director of Finance/CFO | 58 | 15/07/2015 | |
Dana Aftab
COO | Chief Operating Officer | 63 | 01/02/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 01/02/2004 | |
George Poste
BRD | Director/Board Member | 82 | 01/08/2004 |
| Chairman | 77 | 01/01/1998 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.91% | 0.00% | - | - | 15.95B | |
| +0.79% | -6.16% | +49.32% | +74.50% | 66.34B | |
| -0.32% | +6.46% | +11.60% | +90.23% | 52.92B | |
| +0.36% | +4.93% | +7.55% | +73.65% | 54.82B | |
| +0.74% | +2.75% | +26.31% | +45.29% | 44.09B | |
| +3.87% | +10.15% | +20.69% | +132.73% | 43.72B | |
| +7.91% | +4.30% | +263.91% | +602.72% | 42.13B | |
| -0.40% | +9.85% | +17.04% | +59.17% | 33.96B | |
| -1.30% | -0.68% | +37.15% | +7.04% | 26.17B | |
| +0.79% | +5.68% | +36.70% | +26.48% | 23.37B | |
| Average | +1.64% | +4.96% | +52.25% | +123.54% | 43.06B | |
| Weighted average by Cap. | +1.55% | +4.85% | +51.33% | +128.41% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.55B 12.81B 2.27B 2.11B 1.91B 3.59B 242B 3.65B 25.28B 9.93B 127B 9.58B 9.38B 404B | 2.9B 14.56B 2.58B 2.39B 2.17B 4.08B 275B 4.15B 28.73B 11.29B 144B 10.89B 10.66B 459B |
| Net income | 820M 4.12B 730M 677M 613M 1.15B 77.72B 1.17B 8.12B 3.19B 40.67B 3.08B 3.01B 130B | 1B 5.03B 892M 827M 749M 1.41B 94.96B 1.43B 9.92B 3.9B 49.69B 3.76B 3.68B 159B |
| Net Debt | -744M -3.73B -663M -614M -557M -1.05B -70.53B -1.06B -7.37B -2.89B -36.91B -2.79B -2.73B -118B | -1.62B -8.14B -1.44B -1.34B -1.21B -2.28B -154B -2.32B -16.06B -6.31B -80.44B -6.09B -5.96B -257B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EXEL Stock
- E2XE34 Stock
Select your edition
All financial news and data tailored to specific country editions
